# ABCB5

## Overview
ABCB5 is a gene that encodes the ATP-binding cassette subfamily B member 5 protein, which is a transmembrane transporter belonging to the ATP-binding cassette (ABC) superfamily. This protein plays a pivotal role in the efflux of various molecules across cellular membranes, contributing to cellular homeostasis and drug resistance mechanisms. ABCB5 is particularly significant in specific cell populations, such as limbal stem cells and dermal immunoregulatory cells, where it influences processes like cell fusion, tissue plasticity, and immune regulation. The protein's involvement in maintaining corneal epithelial homeostasis and modulating immune responses underscores its importance in tissue renewal and repair. Clinically, ABCB5 is implicated in several malignancies, including melanoma and colorectal cancer, where it is associated with chemoresistance and tumor progression, highlighting its potential as a therapeutic target (Ksander2014ABCB5; Schatton2015ABCB5; Frank2003Regulation).

## Structure
The ABCB5 protein is a member of the ATP-binding cassette (ABC) transporter superfamily, characterized by its role in ATP-dependent transport of various molecules. The full-length ABCB5 isoform consists of 1257 amino acids and features two transmembrane domains (TMDs) and two nucleotide-binding domains (NBDs), which are interconnected by a linker region (Tangella2021Identification; Moitra2011Molecular). Each TMD comprises six alpha-helices, while the NBDs contain eight beta-sheets, forming the ABC signature motifs, Walker A, and Walker B motifs (Tangella2021Identification).

The tertiary structure of ABCB5 involves the folding of these domains to form a central cavity with putative drug binding sites, enclosed by the twelve transmembrane helices (Tangella2021Identification). The quaternary structure may involve dimerization, as suggested by the presence of coiled-coil domains in the beta form, which are crucial for forming the dimeric full transporter from half-transporter monomers (Moitra2011Molecular).

ABCB5 exists in multiple isoforms, including the full-length and ABCB5b isoforms, which function as drug efflux pumps (Tangella2021Identification). Post-translational modifications such as phosphorylation and glycosylation are present, with 14 N-glycosylation sites identified in the full transporter (Moitra2011Molecular).

## Function
ABCB5 is a member of the ATP-binding cassette (ABC) transporter superfamily, which functions as a rhodamine efflux transporter. It plays a crucial role in regulating membrane potential and influences the propensity of progenitor cells to undergo cell fusion, contributing to tissue plasticity and renewal (Frank2003Regulation). ABCB5 is expressed in specific subpopulations of cells, such as limbal stem cells (LSCs) in the eye and dermal immunoregulatory cells in the skin. In LSCs, ABCB5 is essential for maintaining corneal epithelial homeostasis and regeneration by regulating quiescence and anti-apoptotic pathways, which are crucial for corneal development and repair (Ksander2014ABCB5). In the skin, ABCB5 marks a unique subset of dermal cells that coexpress mesenchymal stem cell markers and are involved in immunoregulation, potentially modulating immune responses to maintain cutaneous immune homeostasis (Schatton2015ABCB5). The protein is primarily active in the plasma membrane, where it is involved in the efflux of various molecules, contributing to cellular homeostasis and processes like drug resistance (Frank2003Regulation).

## Clinical Significance
The ABCB5 gene is clinically significant due to its role in various malignancies, including melanoma, colorectal cancer, hepatocellular carcinoma (HCC), and glioblastoma multiforme (GBM). In melanoma, ABCB5 is overexpressed in tumor-initiating cells, contributing to chemoresistance and tumor progression. It is associated with increased tumorigenicity and metastasis, and its expression is enriched following chemotherapy, suggesting a role in treatment resistance and disease recurrence (Borchers2017Detection; Chartrain2012Melanoma).

In colorectal cancer, ABCB5 is linked to multidrug resistance and tumor invasiveness. It enhances cancer cell invasiveness through AXL signaling, and its expression correlates with poor survival outcomes (Guo2018ATPbinding). In HCC, genetic variations in ABCB5 are associated with increased cancer risk and poor prognosis, with elevated expression levels linked to advanced tumor stages and nodal metastasis (Leung2020Genetic).

In GBM, ABCB5 is expressed in chemoresistant tumor-initiating cells and is associated with poor survival. Targeting ABCB5 in GBM cells has been shown to sensitize them to chemotherapy, suggesting its potential as a therapeutic target (Lee2020Targeting).

## Interactions
ABCB5 is known to participate in various interactions with proteins that are crucial for its role in cellular processes. As a member of the ATP-binding cassette (ABC) transporter family, ABCB5 is involved in the transport of diverse molecules across cellular membranes. It interacts with proteins that play significant roles in drug resistance, which is a critical aspect of its function in cellular signaling pathways. These interactions may influence the formation of multiprotein complexes that are essential for modulating cell proliferation and apoptosis. Through these interactions, ABCB5 can affect the cellular response to external stimuli and contribute to the regulation of cell survival and death mechanisms. The ability of ABCB5 to form complexes with other proteins suggests its involvement in intricate cellular networks that govern essential biological processes. These interactions highlight the importance of ABCB5 in maintaining cellular homeostasis and its potential impact on therapeutic strategies targeting drug resistance mechanisms.


## References


[1. (Tangella2021Identification) Lokeswari P. Tangella, Mahreen Arooj, Evelyne Deplazes, Elin S. Gray, and Ricardo L. Mancera. Identification and characterisation of putative drug binding sites in human atp-binding cassette b5 (abcb5) transporter. Computational and Structural Biotechnology Journal, 19:691–704, 2021. URL: http://dx.doi.org/10.1016/j.csbj.2020.12.042, doi:10.1016/j.csbj.2020.12.042. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.csbj.2020.12.042)

[2. (Moitra2011Molecular) Karobi Moitra, Mark Scally, Kate McGee, Germaine Lancaster, Bert Gold, and Michael Dean. Molecular evolutionary analysis of abcb5: the ancestral gene is a full transporter with potentially deleterious single nucleotide polymorphisms. PLoS ONE, 6(1):e16318, January 2011. URL: http://dx.doi.org/10.1371/journal.pone.0016318, doi:10.1371/journal.pone.0016318. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0016318)

[3. (Frank2003Regulation) Natasha Y. Frank, Shona S. Pendse, Peter H. Lapchak, Armen Margaryan, Debbie Shlain, Carsten Doeing, Mohamed H. Sayegh, and Markus H. Frank. Regulation of progenitor cell fusion by abcb5 p-glycoprotein, a novel human atp-binding cassette transporter. Journal of Biological Chemistry, 278(47):47156–47165, November 2003. URL: http://dx.doi.org/10.1074/JBC.M308700200, doi:10.1074/jbc.m308700200. This article has 306 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M308700200)

[4. (Leung2020Genetic) Idy C.‐Y. Leung, Charing C.‐N. Chong, Tan T. Cheung, Philip C. Yeung, Kelvin K.‐C. Ng, Paul B.‐S. Lai, Stephen L. Chan, Anthony W.‐H. Chan, Patrick M.‐K. Tang, and Siu T. Cheung. Genetic variation in abcb5 associates with risk of hepatocellular carcinoma. Journal of Cellular and Molecular Medicine, 24(18):10705–10713, August 2020. URL: http://dx.doi.org/10.1111/jcmm.15691, doi:10.1111/jcmm.15691. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jcmm.15691)

[5. (Borchers2017Detection) S Borchers, C Maβlo, C A Müller, A Tahedl, J Volkind, Y Nowak, V Umansky, J Esterlechner, M H Frank, C Ganss, M A Kluth, and J Utikal. Detection of abcb5 tumour antigen-specific cd8+ t cells in melanoma patients and implications for immunotherapy. Clinical and Experimental Immunology, 191(1):74–83, October 2017. URL: http://dx.doi.org/10.1111/cei.13053, doi:10.1111/cei.13053. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cei.13053)

[6. (Chartrain2012Melanoma) Marine Chartrain, Joëlle Riond, Aline Stennevin, Isabelle Vandenberghe, Bruno Gomes, Laurence Lamant, Nicolas Meyer, Jean Edouard Gairin, Nicolas Guilbaud, and Jean Philippe Annereau. Melanoma chemotherapy leads to the selection of abcb5-expressing cells. PLoS ONE, 7(5):e36762, May 2012. URL: http://dx.doi.org/10.1371/journal.pone.0036762, doi:10.1371/journal.pone.0036762. This article has 85 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0036762)

[7. (Ksander2014ABCB5) Bruce R. Ksander, Paraskevi E. Kolovou, Brian J. Wilson, Karim R. Saab, Qin Guo, Jie Ma, Sean P. McGuire, Meredith S. Gregory, William J. B. Vincent, Victor L. Perez, Fernando Cruz-Guilloty, Winston W. Y. Kao, Mindy K. Call, Budd A. Tucker, Qian Zhan, George F. Murphy, Kira L. Lathrop, Clemens Alt, Luke J. Mortensen, Charles P. Lin, James D. Zieske, Markus H. Frank, and Natasha Y. Frank. Abcb5 is a limbal stem cell gene required for corneal development and repair. Nature, 511(7509):353–357, July 2014. URL: http://dx.doi.org/10.1038/nature13426, doi:10.1038/nature13426. This article has 201 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nature13426)

[8. (Lee2020Targeting) Catherine A.A. Lee, Pallavi Banerjee, Brian J. Wilson, Siyuan Wu, Qin Guo, Gretchen Berg, Svetlana Karpova, Ananda Mishra, John W. Lian, Johnathan Tran, Max Emmerich, George F. Murphy, Markus H. Frank, and Natasha Y. Frank. Targeting the abc transporter abcb5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism. Journal of Biological Chemistry, 295(22):7774–7788, May 2020. URL: http://dx.doi.org/10.1074/jbc.ra120.013778, doi:10.1074/jbc.ra120.013778. This article has 25 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra120.013778)

[9. (Guo2018ATPbinding) Qin Guo, Tanja Grimmig, Gabriel Gonzalez, Anita Giobbie-Hurder, Gretchen Berg, Nolan Carr, Brian J. Wilson, Pallavi Banerjee, Jie Ma, Jason S. Gold, Bisweswar Nandi, Qin Huang, Ana Maria Waaga-Gasser, Christine G. Lian, George F. Murphy, Markus H. Frank, Martin Gasser, and Natasha Y. Frank. Atp-binding cassette member b5 (abcb5) promotes tumor cell invasiveness in human colorectal cancer. Journal of Biological Chemistry, 293(28):11166–11178, July 2018. URL: http://dx.doi.org/10.1074/jbc.ra118.003187, doi:10.1074/jbc.ra118.003187. This article has 49 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.ra118.003187)

[10. (Schatton2015ABCB5) Tobias Schatton, Jun Yang, Sonja Kleffel, Mayuko Uehara, Steven R. Barthel, Christoph Schlapbach, Qian Zhan, Stephen Dudeney, Hansgeorg Mueller, Nayoung Lee, Juliane C. de Vries, Barbara Meier, Seppe Vander Beken, Mark A. Kluth, Christoph Ganss, Arlene H. Sharpe, Ana Maria Waaga-Gasser, Mohamed H. Sayegh, Reza Abdi, Karin Scharffetter-Kochanek, George F. Murphy, Thomas S. Kupper, Natasha Y. Frank, and Markus H. Frank. Abcb5 identifies immunoregulatory dermal cells. Cell Reports, 12(10):1564–1574, September 2015. URL: http://dx.doi.org/10.1016/j.celrep.2015.08.010, doi:10.1016/j.celrep.2015.08.010. This article has 76 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2015.08.010)